Completed PHASE1 INTERVENTIONAL 3-arm NCT03889145

A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide

A Randomized, Open-label, Single Dose, 3-way Crossover Study to Evaluate the Drug-drugs Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

Sponsor: IlDong Pharmaceutical Co Ltd

Conditions Healthy

Interventions Amlodipine10mg Hydrochlorothiazide Telmisartan 80mg

Updated 4 times since 2019 Last updated: Mar 21, 2019 Started: Dec 19, 2013 Primary completion: Feb 19, 2014 Completion: Feb 19, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03889145, this PHASE1 trial focuses on Healthy and remains completed. Sponsored by IlDong Pharmaceutical Co Ltd, it has been updated 4 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Apr 2019 — Jan 2021 [monthly]

Completed PHASE1

First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

IlDong Pharmaceutical Co Ltd

Data source: IlDong Pharmaceutical Co Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.